MIR4669

Across TCGA pan-cancer cohorts, MIR4669 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR4669 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR4669 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4669 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ESCA show a favorable association.

KICH, OV, and BLCA are the cancer types where MIR4669 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
OV	OS	Tertile	II,III,IV	0.751	0.854	.014	72	view →
BLCA	OS	Tertile	All	0.742	0.578	.012	57	view →
THCA	OS	Tertile	II,III,IV	0.709	0.967	<.001	54	view →
PCPG	OS	Tertile	All	0.683	0.975	<.001	27	view →
LIHC	DFS	Tertile	III,IV	0.040	0.334	<.001	27	view →
BRCA	DFS	Tertile	All	0.883	0.951	.003	18	view →
READ	OS	Tertile	III,IV	0.242	0.544	.041	18	view →
SKCM	DFS	Tertile	All	0.443	0.740	.017	12	view →
GBM	OS	Tertile	All	0.214	0.417	.038	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
ESCA	OS	Quartile	III,IV	0.664	0.360	.020	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR4669–KICH (DFS)

Open the KICH breakdown →